Wall Street analysts expect Anthem Inc (NYSE:ANTM) to announce earnings of $5.07 per share for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Anthem’s earnings. The highest EPS estimate is $5.94 and the lowest is $4.66. Anthem posted earnings of $4.68 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 8.3%. The business is expected to announce its next earnings report before the market opens on Wednesday, April 25th.
According to Zacks, analysts expect that Anthem will report full year earnings of $15.10 per share for the current fiscal year, with EPS estimates ranging from $15.03 to $15.20. For the next fiscal year, analysts expect that the firm will post earnings of $16.62 per share, with EPS estimates ranging from $16.11 to $18.00. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that that provide coverage for Anthem.
Anthem (NYSE:ANTM) last announced its quarterly earnings results on Wednesday, January 31st. The company reported $1.29 EPS for the quarter, beating analysts’ consensus estimates of $1.25 by $0.04. Anthem had a return on equity of 12.29% and a net margin of 4.27%. The company had revenue of $22.45 billion during the quarter, compared to analyst estimates of $22.17 billion. During the same period in the prior year, the company earned $1.76 earnings per share. The firm’s revenue was up 4.5% on a year-over-year basis.
A number of equities research analysts have issued reports on the company. Zacks Investment Research downgraded Anthem from a “buy” rating to a “hold” rating in a research report on Tuesday. Barclays assumed coverage on Anthem in a research report on Thursday, March 8th. They set an “overweight” rating and a $270.00 price objective on the stock. ValuEngine upgraded Anthem from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Credit Suisse Group restated an “outperform” rating and set a $280.00 price objective (up from $255.00) on shares of Anthem in a research report on Thursday, February 1st. Finally, Morgan Stanley upped their price objective on Anthem from $247.00 to $266.00 and gave the company an “equal weight” rating in a research report on Thursday, February 1st. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $236.13.
Shares of Anthem stock opened at $220.46 on Tuesday. Anthem has a 12 month low of $164.65 and a 12 month high of $267.95. The company has a market cap of $56,340.65, a P/E ratio of 18.38, a PEG ratio of 1.27 and a beta of 0.90. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.55 and a quick ratio of 1.55.
The firm also recently declared a quarterly dividend, which was paid on Friday, March 23rd. Stockholders of record on Friday, March 9th were issued a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.36%. This is an increase from Anthem’s previous quarterly dividend of $0.70. The ex-dividend date of this dividend was Thursday, March 8th. Anthem’s dividend payout ratio is presently 24.92%.
In other Anthem news, SVP Ronald W. Penczek sold 1,966 shares of the firm’s stock in a transaction on Wednesday, March 7th. The stock was sold at an average price of $231.90, for a total transaction of $455,915.40. Following the transaction, the senior vice president now directly owns 2,132 shares in the company, valued at approximately $494,410.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO John E. Gallina sold 24,576 shares of the firm’s stock in a transaction on Monday, March 5th. The stock was sold at an average price of $229.81, for a total value of $5,647,810.56. Following the transaction, the chief financial officer now owns 22,139 shares in the company, valued at $5,087,763.59. The disclosure for this sale can be found here. Over the last quarter, insiders sold 139,246 shares of company stock worth $32,966,554. Company insiders own 0.31% of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. FineMark National Bank & Trust increased its holdings in Anthem by 8.3% during the 4th quarter. FineMark National Bank & Trust now owns 2,933 shares of the company’s stock worth $660,000 after purchasing an additional 225 shares during the period. Ladenburg Thalmann Financial Services Inc. increased its holdings in Anthem by 2.8% during the 4th quarter. Ladenburg Thalmann Financial Services Inc. now owns 8,451 shares of the company’s stock worth $1,903,000 after purchasing an additional 232 shares during the period. Dowling & Yahnke LLC increased its holdings in Anthem by 3.3% during the 4th quarter. Dowling & Yahnke LLC now owns 7,445 shares of the company’s stock worth $1,675,000 after purchasing an additional 241 shares during the period. Reliance Trust Co. of Delaware increased its holdings in Anthem by 4.7% during the 4th quarter. Reliance Trust Co. of Delaware now owns 5,678 shares of the company’s stock worth $1,278,000 after purchasing an additional 255 shares during the period. Finally, Global X Management Co. LLC increased its holdings in Anthem by 3.8% during the 4th quarter. Global X Management Co. LLC now owns 7,181 shares of the company’s stock worth $1,616,000 after purchasing an additional 263 shares during the period. Institutional investors own 88.28% of the company’s stock.
WARNING: This story was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://ledgergazette.com/2018/04/13/zacks-brokerages-anticipate-anthem-inc-antm-will-post-earnings-of-5-07-per-share.html.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.